Olaparib and Radiotherapy in Inoperable Breast Cancer

Clinical trial NCT02227082 · COMPLETED

Trial details

NCT number: NCT02227082
Sponsor: The Netherlands Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Malignant Neoplasm Inflammatory Breast Carcinoma Triple-Negative Invasive Breast Carcinoma

Start date: 2013-10-21
Primary completion: 2019-09-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.